ATC Φάρμακα Δραστικές ICPC2 ICD10 Ιατρική στην Πράξη Νοσήματα Λοιμώξεις Εμβόλια Πρωτόκολλα
  • Guanabenz
  • indication:For management of High blood pressure
  • pharmacologypharmacology:
  • mechanism: Guanabenz's antihypertensive effect is thought to be due to central alpha-adrenergic stimulation, which results in a decreased sympathetic outflow to the heart, kidneys, and peripheral vasculature in addition to a decreased systolic and diastolic blood pressure and a slight slowing of pulse rate. Chronic administration of guanabenz also causes a decrease in peripheral vascular resistance.
  • toxicity: Excessive contraction of the pupils, irritability, low blood pressure, sleepiness, slow heartbeat, sluggishness
  • absorprion: Approximately 75% absorbed from gastrointestinal tract
  • halflife: 6 hours.
  • roouteelimination:
  • volumedistribution:
  • clearance: